Last reviewed · How we verify
Pro Root MTA
Pro Root MTA, developed by Islamic Azad University, Sanandaj, is a marketed drug with a key composition patent expiring in 2028. The drug's market position and primary indication are not specified, but its key strength lies in its patented composition, which provides a competitive barrier until 2028. The primary risk is the potential for increased competition once the key patent expires in 2028.
At a glance
| Generic name | Pro Root MTA |
|---|---|
| Also known as | Mineral Trioxide Aggregate |
| Sponsor | Islamic Azad University, Sanandaj |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparison Of Clinical And Radiological Success Of Pulpotomy Treatments Performed With Proroot MTA, NeoPUTTY MTA, TheraCal PT In Primary Teeth (NA)
- Clinical and Radiographic Evaluation of Bioceramic Putty MTA Versus MTA in Pulpotomy of Immature Permanent Molars (PHASE3)
- Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth (PHASE2, PHASE3)
- Clinical and Radiographic Evaluation of Pulpotomies in Primary Molars Using Tricalcium Silicate Cements (NA)
- Assessing Success of MTA and Pre-mixed Bioceramic in Mature Teeth With Irreversible Pulpitis With Full Pulpotomy. (PHASE4)
- The Use of Platelet-Rich Fibrin in Partial Pulpotomy Procedure (NA)
- Human Pulpal Response After Pulp Capping With Four Different Agents (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pro Root MTA CI brief — competitive landscape report
- Pro Root MTA updates RSS · CI watch RSS
- Islamic Azad University, Sanandaj portfolio CI